Rituxan (rituximab) - Roche
bendamustine - Generic mfg.
Primary Intermammary Breast Carcinoma Presenting With Direct Sternal Invasion: A Diagnostic Pitfall of Standard Screening Mammography. (PubMed, Am J Case Rep) - Oct 16, 2026 - "CASE REPORT An 85-year-old woman with a past medical history of follicular non-Hodgkin lymphoma treated with bendamustine-rituximab in 2017 (without chest radiation) and significant family history of breast cancer presented to our clinic 2 months after noticing a hard, non-tender nodule on her sternum. CONCLUSIONS This case highlights a rare intermammary presentation of breast carcinoma with direct sternal invasion, a feature not previously reported. It emphasizes the blind spot of standard screening mammography in the medial breast/cleavage area and the necessity of targeted imaging for palpable parasternal masses, even in the setting of recent negative screens." 
Journal • Breast Cancer • Follicular Lymphoma • Hematological Malignancies • HER2 Breast Cancer • HER2 Positive Breast Cancer • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Solid Tumor • HER-2 • PGR
http://www.ncbi.nlm.nih.gov/pubmed/42876016
 
Harsha Choudary Pudhota; Michael Fei; Moustafa Hazin; Rachel Deming; Sonal P Haerter
 
Oct 16, 2026
 
Prev Next